PI3K-IN-35
PI3K-IN-35 (Compound 6l) is a highly selective PI3K inhibitor with IC50 values of 13.98, 7.22 and 10.94 μM for PI3K-α、PI3K-β and PI3K-δ, respectively. PI3K-IN-35 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-35 can be used in leukemia research[1].
Product Specifications
CAS Number
2458163-99-8
UNSPSC
12352005
Target
Apoptosis; PI3K
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3k-in-35.html
Solubility
10 mM in DMSO
Smiles
COC(C=C1)=CC=C1C2=NC(N/N=C/C3=CNC4=C3C=CC=C4)=NC(N5CCOCC5)=C2C#N
Molecular Formula
C25H23N7O2
Molecular Weight
453.50
References & Citations
[1]Helwa AA, et al. Novel antiproliferative agents bearing morpholinopyrimidine scaffold as PI3K inhibitors and apoptosis inducers; design, synthesis and molecular docking. Bioorg Chem. 2020 Sep;102:104051.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα; PI3Kβ; PI3Kδ
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB3527-100 1x 100 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3527), 0.2mg/mL
Sign In for Pricing
View Details